Physician profile
Jesse Peyton Wright
NPI 1174866396
$2,584.51
in general payments reported to CMS, 2019-2025
18 companies · $392 in 2025
The $392 reported for 2025 was more than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $700 · 2020: $50.01 · 2021: $179 · 2022: $554 · 2023: $59.16 · 2024: $651 · 2025: $392.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,102.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,102.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus Corporation of The Americas | $749.61 | 2019-2020 | |
| Medtronic, INC. | $361.89 | 2022-2025 | Interstim, Signia |
| Takeda Pharmaceuticals U.S.A., INC. | $270.06 | 2024-2025 | Gattex |
| Ethicon US, LLC | $197.15 | 2022 | |
| Conmed Corporation | $125.00 | 2021 | |
| Rti Surgical, INC | $121.41 | 2024 | |
| Integra Lifesciences Corporation | $100.49 | 2022 | |
| Stryker Corporation | $84.89 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $78.66 | 2025 | |
| Biotissue Holdings INC. | $77.32 | 2025 | |
| Mimedx Group, INC. | $73.85 | 2024-2025 | |
| Acera Surgical, INC. | $66.29 | 2022-2025 | Restrata Wound Matrix |
| Pacira Pharmaceuticals Incorporated | $63.07 | 2024-2025 | Exparel |
| Medical Device Business Services, INC. | $53.76 | 2021 | |
| Novo Nordisk INC | $50.00 | 2024 | Wegovy |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $49.85 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Boston Scientific Corporation | $38.14 | 2025 | Axonics |
| Tela Bio, INC. | $23.07 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jesse Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.